Global Transportation Excellence Intern
Amgen
Global Transportation Excellence Intern
Amgen
Makes biotech medicines for serious illnesses
Help drive smarter transportation decisions in a global supply chain network
Are you a student with an interest in supply chain, transportation, data analytics, and business decision-making? Would you like to work on a real business challenge within a global biotechnology company and develop solutions that support critical supply chain decisions?
Join our team as a Global Transportation Excellence Intern and become part of a team responsible for developing the transportation systems and capabilities that help ensure medicines reach patients in a timely and cost-effective manner.
Working within a global and dynamic environment, you will contribute to a project focused on improving transportation decision-making through data, analytics, and process optimization. You will help assess current ways of working, identify opportunities for improvement, and develop tools that support faster and better-informed business decisions.
What will you do?
You will support a strategic transportation project by:
Who are we looking for?
You are currently pursuing a Bachelor's or Master's degree in Supply Chain Management, Data Science, Business Analytics, or a related field, and are looking for a final-year internship of approximately 6 months.
You also:
What will you gain?
This internship provides a unique opportunity to gain hands-on experience in global transportation operations and strategic decision-making within an international biotechnology company.
You will also:
Interested?
Send us your CV and motivation letter. Please include your study program, preferred internship period, and availability.
Ready to help shape the future of global transportation decision-making? We look forward to meeting you.
.Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen